Trevena, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative medicines for patients with CNS disorders. The Company has one approved product in the United States, OLINVYK® (oliceridine) injection, indicated in adults for the management of acute pain severe enough to require an intravenous opioid analgesic and for whom alternative treatments are inadequate. The Company's novel pipeline is based on Nobel Prize winning research and includes four differentiated investigational drug candidates: TRV250 for the acute treatment of migraine, TRV734 for maintenance treatment of opioid use disorder, TRV045 for diabetic neuropathic pain and epilepsy, and TRV027 for acute respiratory distress syndrome and abnormal blood clotting in COVID-19 patients.
View Top Employees from Trevena Inc| Website | http://www.trevenainc.com |
| Ticker | TRVN |
| Revenue | $5 million |
| Funding | $64.8 million |
| Employees | View employees |
| Address | 955 Chesterbrook Blvd, Ste 110, Chesterbrook, Pennsylvania 19087, US |
| Phone | (610) 354-8840 |
| Industry | Business Services General, Business Services |
| Competitors | CrystalGenomics, Inc., Destiny Pharma plc, Minerva Neurosciences, Quince Therapeutics, Rexahn Pharmaceuticals |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies |
Looking for a particular Trevena Inc employee's phone or email?
Trevena Inc Questions
The Trevena Inc annual revenue was $5 million in 2024.
Trevena Inc is based in Chesterbrook, Pennsylvania.
The NAICS codes for Trevena Inc are [32, 32541, 325, 3254].
The SIC codes for Trevena Inc are [28, 283].
